Cipher Pharmaceuticals
6560 Kennedy Road
Mississauga
Ontario
L5T 2X4
Canada
Tel: 905-565-0043
Fax: 905-565-1776
230 articles with Cipher Pharmaceuticals
-
Notice of Cipher Pharmaceuticals Annual Meeting of Shareholders
4/1/2008
-
Cipher Pharmaceuticals Reports Fiscal 2007 Year-end Results
2/27/2008
-
Notice of Cipher Pharmaceuticals Fiscal 2007 Fourth Quarter and Year End Conference Call
2/20/2008
-
Cipher Pharmaceuticals Provides CIP-TRAMADOL ER Regulatory Update
2/11/2008
-
Cipher Pharmaceuticals Receives FDA Response to CIP-TRAMADOL ER Appeal
2/1/2008
-
Cipher Pharmaceuticals Provides Product Update
1/8/2008
-
Cipher Pharmaceuticals Appoints Stefan Aigner to Board of Directors
12/6/2007
-
Cipher Pharmaceuticals Appeals FDA's Decision On CIP-TRAMADOL
12/5/2007
-
Cipher Pharmaceuticals Reports Third Quarter Fiscal 2007 Results
11/7/2007
-
Notice of Cipher Pharmaceuticals Fiscal 2007 Third Quarter Conference Call
10/22/2007
-
Cipher Pharmaceuticals Appoints William C. Garriock Chairman of the Board of Directors
10/17/2007
-
Cipher Pharmaceuticals Mourns Passing of Director Waldemar Zimmerman
9/10/2007
-
Notice of Cipher Pharmaceuticals Fiscal 2007 Second Quarter Conference Call
7/13/2007
-
Cipher Pharmaceuticals Enters into U.S. Licensing and Distribution Agreement for Lipofen
7/10/2007
-
Cipher Pharmaceuticals Receives Approvable Letter from FDA for CIP-ISOTRETINOIN; FDA Seeks More Clinical Data
4/27/2007
-
Cipher Pharmaceuticals Annual and Special Meeting of Shareholders
4/13/2007
-
Cipher Pharmaceuticals Reports Fiscal 2006 Year-end Results
3/7/2007
-
Notice of Cipher Pharmaceuticals Conference Call
2/27/2007
-
Cipher Pharmaceuticals's Response To Approvable Letter For CIP-ISOTRETINOIN Accepted For Review By FDA
1/17/2007
-
Notice Of Cipher Pharmaceuticals Conference Call
10/26/2006